Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Women with Ovarian Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:

  • Are a female at least 18 years of age
  • Have a confirmed diagnosis of high-grade serous EOC, primary peritoneal cancer, or fallopian tube cancer
  • Have platinum-resistant disease
  • Have completed any major surgery at least 4 weeks prior to first dose of

MIRV and have recovered or stabilized from the side effects of prior surgery

  • Have adequate hematologic, liver and kidney functions

You may NOT participate in this study if you:

  • Have primary platinum-refractory disease
  • Have folate deficiency (take folate supplements)
  • Have active or chronic corneal disorders, history of corneal transplantation, or active ocular conditions requiring ongoing treatment/monitoring
  • Have a serious concurrent illness or clinically relevant active infection
  • Have a clinically significant cardiac disease
  • Have a history of hemorrhagic or ischemic stroke or a history of cirrhotic liver disease
  • Are pregnant or breastfeeding

Contact Information
Martina Kracikova, Study Coordinator
One Gustave L. Levy Place, Box 1170 New York, NY 10029
Phone: (212)-824-7859
Fax: (212) 824 2347